As GlaxoSmithKline places 500 patents into a pool for use by other drug makers against the payment of royalties, Elizabeth Sukkar looks at further developments
No takes yet. Share an insight, caveat, or question.
E. Sukkar (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context:
More from BMJ